CureVac N.V. (CVAC) — Financial statements
Income statement, balance sheet, and cash flow for CureVac N.V. — annual and quarterly history with growth and margin analysis.
| Metric (EUR Millions) | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 535↑895.5% | 54↓20.3% | 67↓34.5% | 103↑110.6% | 49 | |
| Cost of Revenue | 106↓14.9% | 124↓32.4% | 184↓22.8% | 238↑1580.6% | 14 | |
| Gross Profit | 429↑708.1% | -71↑39.4% | -117↑13.8% | -135↓489.3% | 35 | |
| Operating Expenses | ||||||
| R&D Expenses | 153↑32.2% | 116↑85.0% | 63↓92.3% | 816↑616.9% | 114 | |
| General & Administrative Expenses | 70↓8.4% | 76↓14.6% | 89↑2.1% | 87↑93.7% | 45 | |
| Selling & Marketing Expenses | 4↑948.8% | 0.42↑1.7% | 0.42↓76.1% | 2↑137.8% | 0.73 | |
| SG&A Expenses | 74↓2.7% | 76↓14.5% | 89↑0.5% | 89↑94.4% | 46 | |
| Other Expenses | 24↑112.4% | 11↑164.7% | -18↑97.2% | -628↓72060.1% | -0.87 | |
| Operating Expenses | 252↑23.6% | 204↑51.6% | 134↓51.5% | 277↑74.6% | 159 | |
| Total Costs & Expenses | 357↑9.0% | 328↑3.0% | 318↓38.2% | 515↑224.7% | 159 | |
| Operating Results | ||||||
| Operating Income | 178↑164.8% | -274↓9.9% | -249↑39.5% | -412↓232.5% | -124 | |
| Depreciation & Amortization | 19↓19.6% | 23↓10.6% | 26↓27.1% | 36↑163.6% | 14 | |
| EBITDA | 210↑189.6% | -234↓11.8% | -209↑45.8% | -386↓214.0% | -123 | |
| EBIT | 191↑174.1% | -257↓4.9% | -245↑39.0% | -402↓273.3% | -108 | |
| Interest & Other Income | ||||||
| Net Interest Income | 12↓13.2% | 14↑4614.6% | 0.30↑228.5% | -0.24↑98.8% | -20 | |
| Interest Income | 12↓26.1% | 17↑317.3% | 4↓60.3% | 10↑388.1% | 2 | |
| Interest Expense | 0.00↓100.0% | 2↓32.7% | 4↓64.1% | 10↓53.2% | 22 | |
| Non-Operating Income | -13↑21.1% | -17↓317.3% | -4↑60.3% | -10↓388.1% | -2 | |
| Other Income / Expenses | 13↓7.3% | 14↑4614.6% | 0.30↑228.5% | -0.24↑98.8% | -20 | |
| Income Before Tax | 191↑173.4% | -260↓4.3% | -249↑39.6% | -412↓217.8% | -130 | |
| Income Tax Expense | 29↑14392.4% | 0.20↑257.1% | -0.13↑83.9% | -0.78↓7.7% | -0.73 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | 162↑162.3% | -260↓4.5% | -249↑39.5% | -412↓218.9% | -129 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | 162↑162.3% | -260↓4.5% | -249↑39.5% | -412↓219.0% | -129 | |
| Bottom-Line Net Income | 162↑162.3% | -260↓4.5% | -249↑39.5% | -412↓218.9% | -129 | |
| EPS (Basic) | 0.72↑161.0% | -1.18↑10.6% | -1.32↑40.3% | -2.21↓125.5% | -0.98 | |
| EPS (Diluted) | 0.72↑161.0% | -1.18↑10.6% | -1.32↑40.3% | -2.21↓125.5% | -0.98 | |
| Weighted Average Shares | 224↑1.8% | 220↑16.6% | 189↑1.6% | 186↑40.7% | 132 | |
| Weighted Average Diluted Shares | 225↑2.0% | 221↑16.8% | 189↑1.6% | 186↑40.7% | 132 | |
* All figures in Millions of EUR, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.